These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 10724038

  • 1. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice.
    Haag A, Menten P, Van Damme J, Dinsart C, Rommelaere J, Cornelis JJ.
    Hum Gene Ther; 2000 Mar 01; 11(4):597-609. PubMed ID: 10724038
    [Abstract] [Full Text] [Related]

  • 2. Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts.
    Wetzel K, Menten P, Opdënakker G, Van Damme J, Gröne HJ, Giese N, Vecchi A, Sozzani S, Cornelis JJ, Rommelaere J, Dinsart C.
    J Gene Med; 2001 Mar 01; 3(4):326-37. PubMed ID: 11529662
    [Abstract] [Full Text] [Related]

  • 3. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.
    Moehler M, Blechacz B, Weiskopf N, Zeidler M, Stremmel W, Rommelaere J, Galle PR, Cornelis JJ.
    Cancer Gene Ther; 2001 Mar 01; 8(3):158-67. PubMed ID: 11332986
    [Abstract] [Full Text] [Related]

  • 4. Production of recombinant H1 parvovirus stocks devoid of replication-competent viruses.
    Brown CS, DiSumma FM, Rommelaere J, Dege AY, Cornelis JJ, Dinsart C, Spaan WJ.
    Hum Gene Ther; 2002 Dec 10; 13(18):2135-45. PubMed ID: 12542845
    [Abstract] [Full Text] [Related]

  • 5. MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells.
    Wetzel K, Struyf S, Van Damme J, Kayser T, Vecchi A, Sozzani S, Rommelaere J, Cornelis JJ, Dinsart C.
    Int J Cancer; 2007 Mar 15; 120(6):1364-71. PubMed ID: 17154174
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin.
    Olijslagers S, Dege AY, Dinsart C, Voorhoeve M, Rommelaere J, Noteborn MH, Cornelis JJ.
    Cancer Gene Ther; 2001 Dec 15; 8(12):958-65. PubMed ID: 11781658
    [Abstract] [Full Text] [Related]

  • 7. Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.
    Giese NA, Raykov Z, DeMartino L, Vecchi A, Sozzani S, Dinsart C, Cornelis JJ, Rommelaere J.
    Cancer Gene Ther; 2002 May 15; 9(5):432-42. PubMed ID: 11961666
    [Abstract] [Full Text] [Related]

  • 8. Vectors based on autonomous parvoviruses: novel tools to treat cancer?
    Cornelis JJ, Salomé N, Dinsart C, Rommelaere J.
    J Gene Med; 2004 Feb 15; 6 Suppl 1():S193-202. PubMed ID: 14978762
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Species specificity for transduction of cultured cells by a recombinant LuIII rodent parvovirus genome encapsidated by canine parvovirus or feline panleukopenia virus.
    Spitzer AL, Maxwell F, Corsini J, Maxwell IH.
    J Gen Virol; 1996 Aug 15; 77 ( Pt 8)():1787-92. PubMed ID: 8760427
    [Abstract] [Full Text] [Related]

  • 11. Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells.
    Moehler M, Zeidler M, Schede J, Rommelaere J, Galle PR, Cornelis JJ, Heike M.
    Cancer Gene Ther; 2003 Jun 15; 10(6):477-80. PubMed ID: 12768193
    [Abstract] [Full Text] [Related]

  • 12. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.
    Brandenburger A, Velu T.
    J Gene Med; 2004 Feb 15; 6 Suppl 1():S203-11. PubMed ID: 14978763
    [Abstract] [Full Text] [Related]

  • 16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

  • 17. In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.
    El Bakkouri K, Servais C, Clément N, Cheong SC, Franssen JD, Velu T, Brandenburger A.
    J Gene Med; 2005 Feb 01; 7(2):189-97. PubMed ID: 15515141
    [Abstract] [Full Text] [Related]

  • 18. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA, Ren C, White AF, Zhou SZ, Kumar S, Jenkins CB, Shaw DR, Strong TV, Triozzi PL, Ponnazhagan S.
    Gene Ther; 2006 Jan 01; 13(1):29-39. PubMed ID: 16136165
    [Abstract] [Full Text] [Related]

  • 19. Augmented transgene expression in transformed cells using a parvoviral hybrid vector.
    Krüger L, Eskerski H, Dinsart C, Cornelis J, Rommelaere J, Haberkorn U, Kleinschmidt JA.
    Cancer Gene Ther; 2008 Apr 01; 15(4):252-67. PubMed ID: 18202715
    [Abstract] [Full Text] [Related]

  • 20. The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.
    Lang SI, Boelz S, Stroh-Dege AY, Rommelaere J, Dinsart C, Cornelis JJ.
    J Virol; 2005 Jan 01; 79(1):289-98. PubMed ID: 15596824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.